Walgreens Stock Plummets Over 12% Following DOJ Opioid Lawsuit
Walgreens Boots Alliance Inc.'s shares fell over 12% after the DOJ filed a lawsuit accusing it of dispensing prescriptions for opioids without a legitimate medical purpose, potenti...
Walgreens Boots Alliance Inc.'s shares fell over 12% after the DOJ filed a lawsuit accusing it of dispensing prescriptions for opioids without a legitimate medical purpose, potenti...
The U.S. Department of Justice has filed a lawsuit against Walgreens for allegedly dispensing millions of prescriptions without a legitimate medical purpose, including excessive qu...
Walgreens Boots Alliance Inc. experienced a 25% surge in its shares following a strong Q1 performance, with sales revenue up 7.5% year-over-year to $39.5 billion. CEO Tim Wentworth...
Walgreens Boots Alliance Inc. has reported a Q1 net loss of $265 million, a significant increase from the previous year's $67 million loss. This development underscores the challen...
Walgreens Boots Alliance Inc. is reportedly in talks to sell itself to New York-based private equity firm Sycamore Partners, a move that could take the company private after a deca...